Toxicology - sums.ac.ir

Download Report

Transcript Toxicology - sums.ac.ir

IN THE NAME OF GOD

AN APPROACH TO A POISONED PATIENT

DR. FAZEL GOUDARZI;TRAUMATO PATHOLOGIST AND CLINICAL TOXICOLOGIST SHIRAZ UNIVERCITY OF MEDICAL SCIENCES

Introduction

What is a poison?

 In common usage - poisons are chemicals or chemical products that are distinctly harmful to human  More precisely - a poison is a foreign chemical (xenobiotic) that is capable of producing a harmful effect on a biologic system

Other terminology

What is a toxin?

 It originally referred to a poison of animal or plant origin  Toxicant is the currently preferred scientific term for all poisons.

Epidemiology     Ingestion of a potentially poisonous substance by a young child is common.

American Association of Poison Control Centers reported 1.2 million ingestions in children < 6 years of age in 2001. Death is uncommon in this age group.

Decline in death rate from 500 mortalities per year in the 1940s to 25 mortalities in 1997

Epidemiology Decline in mortality attributed to:      child resistant containers safer medications anticipatory guidance public education legislation    establishment of poison control centers sophisticated medical care antidotes

Clinical assessment

Approach to the Poisoned Patient History  Time of ingestion  Medications in the household  Amount ingested  Onset of symptoms  Intentionality  Underlying medical conditions

Approach to the Poisoned Patient Physical Examination        Vital Signs Pupillary exam (miosis, mydriasis) Skin (dry, cyanotic) Lungs (crackles, wheezing) Cardiac (tachycardia, bradycardia) Abdomen (decreased bowel sounds, tenderness) Neurologic (altered mental status, seizure)

Approach to the Poisoned Patient Initial Management  Airway  Breathing  Circulation  Disability  Exposure

Clinical assessment

Airway - ensure clear airway, clear secretions, check for cough/gag

Breathing - check oxygenation, supplemental O2, breathing pattern & adequacy

Circulation - heart rate, rhythm, blood pressure

Clinical assessment

Neurologic - GCS, seizures, agitation, spasms, pupils, autonomic dysfunction

Miscellaneous - odour, temperature, pallor, cyanosis, jaundice

Abdomen - rigidity, bleeding, urine output

Laboratory and imaging(paraclinical) assessment

Approach to the Poisoned Patient Diagnostic Evaluation  CBCD  Electrolytes  ABG  LFTs  CXR  ECG  AXR  Serum Tox  Urine Tox  ASA level  Tylenol level  Serum OSM  Cholinstrase

Laboratory assessment

  

Electrolytes

 

Hypokalemia

Oduvanthalai poisoning (Clistanthis collinis)Diuretics, Methyl xanthine, Toluene

Hyperkalemia

DigoxinBeta-blocker

Liver function tests

Acetaminophen, Ethanol, Carbon tetrachloride

Renal function tests

Ethylene glycol, NSAIDS

Anion Gap (AG)

Anion Gap = Na

+

- [Cl

-

+ HCO

3 -

] Normal AG: 8-16

Toxins associated with increased AG         Methanol Paraldehyde INH Fe Ethylene glycol Salicylates CO Cyanide  Hydrogen Sulfide  ETOH (ketones)  Metformin  Phenformin  Sulfur  Theophylline  Toluene

Toxins associated with decreased AG  Lithium  Bromide

Osmolal Gap (OG)

Serum OSM: 2[Na] + [ Glc]/18 + [BUN]/2.6

OG: Measured OSM-Calculated OSM Normal OG: -3 to 10 mOSM/kg H2O

Toxins associated with increased OG  Methanol  Ethanol  Ethylene glycol  Acetone  Isopropanol

Useful Toxin Levels         Set time point Acetaminophen Carbon Monoxide Ethanol Ethylene glycol Heavy metals Iron Methanol Methemoglobin         Serial levels Salicylates Carbamazepine Digoxin lithium Phenobarbital Phenytoin Theophylline Valproate

ECG and Imaging Assessment

ECG

Digoxin toxicity

TCA overdose - sinus tachycardia, QT prolongation, increased QRS

Beta-blockers - conduction abnormalities

Imaging

Chest x-ray

Abdominal x-ray

 

Cervical x-ray (lateral) C.T scan or MRI in decrease L.O.C.

Radiopaque drugs          Bezoars/Bags Calcium carbonate Chloral hydrate Enteric-coated tablets Heavy metals Iodine Fe Phenothiazines Potassium compounds

Other terminology

What is a toxidrome?(TOXICOLOGIC SYNDROME)?

 It is the association of several clinically recognizable features, signs, symptoms, phenomena or characteristics which often occur together others. , so that the presence of one feature alerts the physician to the presence of the

Common toxidromes

Opiate toxidrome

Opiate toxidrome

Opiate toxidrome

Toxidromes Opiates  Miosis  Respiratory depression  Cns depression  Hypotension  Sedation  Decreased GI motility  Urinary retention

Toxidromes Opiates  Seizures-Meperidine; occur secondary to the metabolite normeperidine  Dysrhythmias-Propoxyphene; occur from the metabolite norpropoxyphene  Rigid Chest-Fentanyl

Common toxidromes

The cholinergic toxidrome

The cholinergic toxidrome

The cholinergic toxidrome

Toxidromes Cholinergics-Muscarinic Effects  Salivation  Lacrimation  Urination  Defecation  Gastrointestinal Distress  Emesis

TOXIDROME CHOLINERGIC CNS EFFECT  RESTLESSNESS  AGITATION  CONFUSION  CONVULSION   COMA DEATH

Toxidromes Cholinergics-Nicotinic Effects  Muscle Fasciculations  Weakness  Paralysis  Sympathomimetic effect

What toxidrome?

The anticholinergic toxidrome

Hot as a hare Dry as a bone Red as a beet Mad as a hatter Blind as a bat

The anticholinergic toxidrome

Hot as a hare Dry as a bone Red as a beet Mad as a hatter Blind as a bat

The anticholinergic toxidrome

Hot as a hare Dry as a bone Red as a beet Mad as a hatter Blind as a bat

Toxidromes Anticholinergics       “Red as a beet”- Flushed skin “Hot as a hare”-Hyperthermia “Mad as a hatter”-Psychosis “Dry as a bone”-Dry skin, urinary retention Tachycardia Mydriasis

What toxidrome?

Hallucinogenic Toxidrome disorientation hallucinations hyperactive bowel panic seizure Hypertension Tachycardia Tachypnea Amphetamine Cocaine Pseudoephedrine Phencyclidine Ephedrine Benzodiazepenes

Hallucinogenic Sympathomimetic toxidrome

Hallucinogenic and stimulants Toxidrome disorientation hallucinations Amphetamine Cocaine hyperactive bowel panic seizure Hypertension Tachycardia Tachypnea Pseudoephedrine Phencyclidine Ephedrine Benzodiazepenes

Hallucinogenic Sympathomimetic toxidrome

Hallucinogenic Toxidrome disorientation hallucinations hyperactive bowel panic seizure Hypertension Tachycardia Tachypnea Amphetamine Cocaine Pseudoephedrine Phencyclidine Ephedrine Benzodiazepenes

Hallucinogenic Sympathomimetic toxidrome

Hallucinogenic Toxidrome disorientation hallucinations hyperactive bowel panic seizure Hypertension Tachycardia Tachypnea Amphetamine Cocaine Pseudoephedrine Phencyclidine Ephedrine Benzodiazepenes

Hallucinogenic Sympathomimetic toxidrome

Hallucinogenic Toxidrome disorientation hallucinations hyperactive bowel panic seizure Hypertension Tachycardia Tachypnea Amphetamine Cocaine Pseudoephedrine Phencyclidine Ephedrine Benzodiazepenes

Common toxidromes

Sedative/hypnotic toxidrome

Sedative/hypnotic toxidrome

Sedative/hypnotic toxidrome

Common toxidromes

Serotonergic syndrome

Serotonergic syndrome

Serotonergic syndrome

Toxidromes Sympathomimetics  Hypertension  Tachycardia  Psychomotor Agitation  Hyperthermia  Diaphoresis  Mydriasis

Recognition of poisoning

May be difficult because of non-specific symptoms

High index of suspicion - especially occult poisoning

 

history may be unreliable look for corroborative history - missing pills, empty container

Course that a poison runs (toxidromes) ! - may help

Toxicology screening - helpful only in a few

Clinical manifestations

Very diverse and varied - depends on the poison

Clinical examination should be focused on the possible manifestations of common poisons in the geographical area

Clinical manifestations

Skin and mucosal damage

Neurotoxic manifestations

Cardiovascular manifestations

Metabolic consequences

Eye manifestations

Hepatic dysfunction

When do you consider ICU?

Respiratory

Airway protection

Respiratory failure

Cardiovascular

Hypotension despite fluid challenge

Heart block, arrhythmias, QTc prolongation as in TCA

When do you consider ICU?

Neurologic

 

GCS < 8 (grade 3 and4) Seizures

Metabolic

Hypoglycaemia

   

Significant electrolyte abnormalities metabolic acidosis Hepatic failure Coagulopathy with bleeding

Goals of treatment

Goals of treatment

Reduce absorption of the toxin (xenobiotic)

Enhance elimination

Neutralise toxin

Reduce absorption of the toxin

Reduce absorption

      

Removal from surface skin & eye Emesis induction Gastric lavage Activated charcoal administration & cathartics Dilution - milk/other drinks for corrosives Whole bowel irrigation Endoscopic or surgical removal of ingested chemical

Reduce absorption 

Skin decontamination

Important aspect – not to be neglectedRemove contaminated clothingWash with soap and water (soaps

containing 30% ethanol advocated)

However, no evidence for benefit even in

OP poisoning

Decontamination 

Gastric decontamination

Forced emesis if patient is awake by gag

stimulation or by ipecac(?)

Gastric lavageActivated charcoal 1g/kg and MDAC in

some cases

Sorbitol as catharticWhole bowel irrigation

Ipecac  NO!!!!

 Had been previously been recommended for administration at home immediately following ingestion  ( No longer recommended in the AAP policy statement - Poison Treatment in the Home Pediatrics Vol. 112 No. 5, November 2003)

Why Not Ipecac?

   Variable percentage of removal of toxic medication In adult volunteers: 51-83% removal (5 minutes after ingestion) 2-59% removal (30 minutes after ingestion) May cause persistent vomiting, lethargy, and diarrhea Vomiting may preclude later administration of oral antidotes

Why Not Ipecac?

    Lethargy and vomiting together increase risk of aspiration Inappropriate use-following ingestion of acid or lye Misuse-children with eating disorders Misuse-Munchausen by proxy

Gastric Lavage  Early following ingestion  Airway must be protected  Use the largest available tube (40 French)  Contraindicated in caustic ingestions, hydrocarbons, previous vomiting

Reduce absorption 

Gastric lavage

Gastric lavage decreases absorption by 42% if done 20 min and by 16% if performed at 60 min

     

Performed by first aspirating the stomach and then repetitively instilling & aspirating fluid Left lateral position better - delays spont. absorption No evidence that larger tube better Simplest, quickest & least expensive way - funnel Choice of fluid is tap water - 5-10 ml/kg Choice of fluid is NL SALIN for children

Reduce absorption 

Gastric lavage

 

Preferrably done on awake patients Presence of an ET tube does not preclude aspiration, though preferred if GCS is low

Activated Charcoal Single Dose  Toxic ingestions that adhere to charcoal  Dose is 1 g/kg PO or NGT  Administered with Sorbitol  Airway must be protected  Contraindicated in caustics, hydrocarbon, foreign body, ileus or gastric perforation

Activated Charcoal Multiple Doses  Large ingestions  Drugs that undergo enterohepatic circulation   Drugs with low V d Drugs with low protein binding  Drugs with long t 1/2

Activated Charcoal Multiple Doses  Only the FIRST dose should be administered with Sorbitol  Dose 1 g/kg PO or NGT Q6 x 24 hours or until charcoal is passed in the stool

Which drugs do not adsorb to charcoal?

 Lithium  Iron  Alcohols  Acids  Alkalis  Cyanide  Hydrocarbons

Whole Bowel Irrigation  Life threatening ingestion  Sustained-release toxin  Prolonged absorption time of the toxin  Must protect the airway  Contraindicated in caustic, hydrocarbon, foreign body, ileus, gastric perforation

Whole Bowel Irrigation Polyethylene Glycol  Dose: up to 500 ml/h  Continue until stool is clear  Patient may get bloated and vomit  Antiemetics (metoclopramide or ondansetron) may be helpful  Monitor electrolytes closely

Toxins and their Antidotes Acetaminophen N-acetylcysteine Anticholinergics Anticholinesterases/ Cholinergics Physostigmine Atropine (muscarinic effects) Pralidoxime (nicotinic effects) -controversial in carbamate ingestions

Toxins and their Antidotes Benzodiazepines Botulism Beta-blockers Calcium channel blockers Carbon monoxide Cyanide, Nitrites Flumazenil Botulinum antitoxin Glucagon Calcium Hyperbaric O 2 , O 2 Amil nitrit;Na nitrit(300mg/10ml); ;Sodium Na thiosulfate(12.5g/50ml)

Toxins and their Antidotes Digoxin Digibind aka Digoxin Fab antibodies Ethylene Glycol Ethanol Heparin Iron Isoniazid Protamine Deferoxamine Pyridoxine

Toxins and their Antidotes Lead Methanol Methemoglobin Opioids EDTA, BAL, DMSA Ethanol Methylene blue Naloxone Tricyclic antidepressants Warfarin (Superwarfarins) NaHCO3 Vitamin K

Enhance elimination

Enhance elimination

Increased elimination is possible only if

   

the drug is distributed predominantly in the ECF has a low protein binding the induced rate of elimination is faster than the normal rate hazards of having a longer time of exposure to the drug are potentially fatal

Enhance elimination

Methods

  

Keep a good urine output 150-200 ml/hr Alkalinisation of urine - clinical efficacy accepted for salicylate & phenobarbital poisoning Extracorporeal removal

Hemodialysis - Barbiturates, Salicylates,

Acetaminophen, Valproate, Alcohols, Glycols

Hemoperfusion - theophylline, digitalis, lipid

soluble drugs

Enhance Elimination Methods  Alkalinization and Urinary ion trapping  Hemodialysis  Charcoal hemoperfusion

Alkalinization/Urinary Ion Trapping  Effective for drugs that are excreted renally  The drugs must be either weak acids or weak bases e.g. ASA and Phenobarbital HA  pKa H + +A At a Urine pH < pKa Non-ionized form *Not excreted in urine At a Urine pH > pKa Ionized form *Excreted in urine

Hemodialysis  Low volume of distribution less than 1L/Kg  Low protein binding  Low molecular weight less than 500 DAL.  Also helpful in managing acidosis, electrolyte abnormalities  Low fat solubility  High Water Solubility

Which drugs are high dialyzable?

 Salicylates  Methanol and ethanol  Lithium  Ethylene glycol  Amphetamines  Theophylline  Vancomycin

(p. brophy) CVVHD following HD for Lithium i L

5

Li Therapeutic range 0.5-1.5 mEq/L

Pt #1 Pt #2

CVVHD started m E q / L

4 3 2 1 0 0 5

Hours

6 12

CT-190 (HD) Multiflo-60 both patients BFR-pt #1 200 ml/min HD & CVVHD -pt # 2 325 ml/min HD & 200 ml/min CVVHD

24

PO 4 Based dialysate at 2L/1.73m

2 /hr

Hemoperfusion      Blood is passed through a cartridge containing charcoal or carbon Drugs with low Vd Toxins can be larger than those removed by hemodialysis Can be more protein bound than those cleared by hemodialysis Toxin must bind well to charcoal

Which drugs can be removed by hemoperfusion?

 Theophylline  Phenobarbital  Carbamazepine  Phenytoin  Salicylates  Paraquate

Complications of Hemoperfusion  Thrombocytopenia  Hypocalcemia  Leukopenia  Rigors

(p. brophy)  HEMOFILTRATION  optimal drug characteristics for removal:  relative molecular mass less than the cut-off of the filter fibres (usually < 40,000)   small Vd (< 1 L/Kg) single compartment kinetics  low endogenous clearance (< 4ml/Kg/min)  (Pond, SM - Med J Australia 1991; 154: 617-622)

(p. brophy)  Continuous Detoxification methods  CAVHF, CAVHD, CAVHP, CVVHF, CVVHD, CVVHP  Indicated in cases where removal of plasma toxin is then replaced by redistributed toxin from tissue  Can be combined with acute high flux HD

(p. brophy)  Intoxicants amenable to Hemofiltration        vancomycin methanol procainamide hirudin thallium lithium methotrexate

(p. brophy)  Plasmapheresis / Exchange Blood Transfusions   Plasmapheresis (Seyffart G. Trans Am Soc Artif Intern Organs 1982; 28:673)  role in intoxication not clearly established  most useful for highly protein bound agents Exchange Blood Transfusions  Pediatric experience > than adult  Methemoglobinemia  overall very limited role in poisoning

Summary 

Poisoning a common problem in our country

A high index of suspicion required to diagnose

Know common toxidrome

Don’t panic and follow a plan of action

 

Decreasing absorption Enhancing elimination

Neutralising toxins

Avoid potentially harmful Rxs - risk vs benefit

Thank you

Case Presentation 1

A 15 year old girl presents to the ED four hours after taking 20 extra-strength (500 mg/tablet) Tylenol tablets. The ingestion was prompted by a fight with her boyfriend earlier that day. She has a history of an attempted suicide in the past. She is awake and alert with stable vital signs. She complains of nausea and has had one episode of vomiting. Physical exam is normal. Baseline labs show normal electrolytes, with normal LFTs, normal coags and a Tylenol level of 120 microgram/ml.

What would you do?

    A. Call psychiatry to evaluate the patient. No medical intervention is required.

B. Administer 1g/kg of activated charcoal with sorbitol every 6 hours and 17 doses of oral N-acetylcysteine.

C. Administer one dose of activated charcoal with sorbitol followed by intravenous N-acetylcysteine for 21 hours.

D. Gastric lavage in an attempt to recover pill fragments.

Acetaminophen Poisoning  Toxic dose: 150 mg/kg or a total dose of 7.5 g  Toxic level: 150 microgram/ml at 4 hours  Antidote: N-acetylcysteine

Acetaminophen Metabolism    90% undergoes glucuronidation and sulfate conjugation in the liver to harmless metabolites excreted in the kidney < 5%, together with some insignificant metabolites are excreted in the kidney unchanged Remainder undergoes oxidation by the cyt-p450 system to N-acetyl-p benzoquinoneimine (NAPQI)

NAPQI  Electrophile  Covalently binds to hepatocytes  Results in cell death  Half life is about

POTENTIAL TOXICITY 

Acute: 7g (10g)

Chronic: 4g per day (7g)

Susceptible patients (alcoholics, ACs, INH)

 

Similar risk for acute ingestion Potential higher risk in chronic ingestions (4g)

Phases of Toxicity  I: (½-24 h):nausea, vomiting, diaphoresis  May be normal II: (24-72 h): less nausea, vomiting; RUQ pain; LFTs and coags begin to rise  III: (72-96 h): Coagulation abnormalities, renal failure, encephalopathy, death related to hepatic failure  IV: (4 d-2 wk):If stage III damage is reversible, resolution of hepatic dysfunction

N-ACETYLCYSTEINE 

Very effective – 100% within 8 hours

Oral in U.S. – IV in Europe

Dose: 140mg/kg load, 70mg/kg Q 4hrs

Traditional – 72 hours

Short course – reassess at 20 hours

INTRAVENOUS NAC 

Oral preparation vs Acetadote ®

Concern is anaphylactoid reactions

Indications:

Can’t tolerate oral NAC

   

Contraindication to oral therapy Ongoing GI decon (coingestant) Fulminant hepatic failure?

Pregnant patient?

N-acetylcysteine (NAC) mechanism  Prevents binding of NAPQI to hepatocytes  Reduces NAPQI  Conjugates NAPQI  Increases sulfation metabolism***

NAC  Must be administered within 8 hours  IV dose: 150 mg/kg infused over 60 minutes; followed by a 4-hour infusion of 50 mg/kg; followed by a 16-hour infusion of 100 mg/kg; equivalent to a total dose of 300 mg/kg infused over 21 hours  Oral dose: 140 mg/kg x 1 followed by 70 mg/kg x 17 doses

NAC      Smells like rotten eggs Oral formulation may need to be given via NGT Dilute with juice Use metoclopramide or ondansetron if not tolerated due to vomiting Use hydrocortisoe and antihistamin in sensitvity cases

 Review of case

A 15 year old girl presents to the ED four hours after taking 20 extra-strength (500 mg/tablet) Tylenol tablets. The ingestion was prompted by a fight with her boyfriend earlier that day. She has a history of an attempted suicide in the past. She is awake and alert with stable vital signs. She complains of nausea and has had one episode of vomiting. Physical exam is normal. Baseline labs show normal electrolytes, with normal LFTs, normal coags and a Tylenol level of 120 microgram/ml.

What would you do for our patient?

    A. Call psychiatry to evaluate the patient. No medical intervention is required.

B. Administer 1g/kg of activated charcoal with sorbitol every 6 hours and 17 doses of oral N-acetylcysteine.

C. Administer one dose of activated charcoal with sorbitol followed by intravenous N-acetylcysteine for 21 hours.

D. Gastric lavage in an attempt to recover pill fragments.

The correct answer is: C. Administer one dose of activated charcoal with sorbitol followed by intravenous N-acetylcysteine for 21 hours.

Key Points    Despite the fact that our patient’s Tylenol level was only 120 microgram/ml at four hours and falls below the toxic level on the nomogram, she must be treated with NAC. She ingested a total of 10 g (20 tablets x 500 mg) which is > 7.5 g and toxic.

NAC may be given orally or IV. IV NAC has only recently been approved for use in the US.

Key Points    The administration of activated charcoal in Tylenol ingestion has been controversial as it may interfere with oral NAC.

Some studies have shown decreased absorption of Tylenol when activated charcoal is given in a timely fashion.

Activated charcoal will not interfere with administration of IV NAC and therefore may be given.

Key Points  If activated charcoal is administered, only one dose should be given.

 For ingestions requiring administration of multiple doses of charcoal, only the first should be given with sorbitol.  Gastric lavage is not likely to be efficacious four hours following ingestion.